Indication

Morphea

Morphea, also known as localized scleroderma, is a rare chronic autoimmune connective tissue disorder characterized by localized inflammation, excessive collagen deposition, and sclerosis of the skin and underlying tissues. Read more about Morphea

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Morphea therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Morphea preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Morphea.

Morphea, also known as localized scleroderma, is a rare chronic autoimmune connective tissue disorder characterized by localized inflammation, excessive collagen deposition, and sclerosis of the skin and underlying tissues.

The disease most commonly affects children and middle-aged adults, with a marked predilection for females.

Clinically, active lesions present as erythematous or violaceous inflammatory plaques that gradually progress to indurated, ivory-white, or hyperpigmented sclerotic areas with tissue atrophy.

While it typically spares internal organs and lacks the systemic vasculopathy of systemic sclerosis, deeper involvement of subcutaneous fat, fascia, muscle, or bone can lead to joint contractures, limb asymmetry, and functional impairment.

Personalize your experience

Follow Morphea and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it